UAB’s Epilepsy Center is housed in the Department of Neurology under the direction of Jerzy Szaflarski, M.D., Ph.D.
UAB has teamed with the Michael J. Fox Foundation to look for genetic biomarkers for Parkinson’s disease.
Researchers show that high-intensity strength training improves mobility, mood and overall quality of life for Parkinson’s patients.
Erik Roberson, M.D., Ph.D., and Andrew West, Ph.D., have been named co-directors of the Center for Neurodegeneration and Experimental Therapeutics.
Gel form of a medication for Parkinson’s disease speeds response time over traditional pills.
Scott Plutchak's diagnosis of transverse myelitis exposed him to a quality of medical communication not often encountered.
Researchers try to answer why to improve targets for further declines in strokes.
Studies zero in on potential biomarkers in muscle tissue for Lou Gehrig’s disease.
A UAB study discovers a pathway used by malignant tumor cells to invade healthy parts of the brain, giving researchers a fresh target for drug discovery.
A grant will establish the new Bachmann-Strauss Dystonia and Parkinson’s Disease Centers of Excellence at UAB and two other medical centers.